Evidence map›Paper›PMID 21199325›Full record

ArticleJournal of cellular and molecular medicine2011

Endothelial progenitor cells are integrated in newly formed capillaries and alter adjacent fibrovascular tissue after subcutaneous implantation in a fibrin matrix.

Oliver Bleiziffer, Matthias Hammon, Elisabeth Naschberger, Karoline Lipnik, Andreas Arkudas, Subha Rath, Galyna Pryymachuk, Justus P Beier, Michael Stürzl, Raymund E Horch and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of cellular and molecular medicine, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. [Osteomyelitis: treatment concepts from the plastic surgeon's point of view].Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen · 2013
    Review
  16. Cancer research by means of tissue engineering--is there a rationale?Journal of cellular and molecular medicine · 2013
    Review
  17. Article
  18. Article
  19. Article
  20. [Pathogenesis, classification and diagnosis of necrotizing soft tissue infections].Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen · 2012
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 3 countries.

Oliver BleizifferDepartment of Plastic and Hand Surgery, University Hospital Erlangen, Erlangen, Germany.
Matthias Hammon
Elisabeth Naschberger
Karoline Lipnik
Andreas Arkudas
Subha Rath
Galyna Pryymachuk
Justus P Beier
Michael Stürzl
Raymund E Horch
Ulrich Kneser
Universitätsklinikum Erlangen · DEUniversity of Veterinary Medicine Vienna · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vascularization of bioartificial matrices is crucial for successful tissue engineering. Endothelial progenitor cells (EPC) have shown vascularization potential in ischemic conditions and may also support blood vessel formation in tissue-engineered matrices. The aim of our study was to investigate the impact of a well-characterized murine embryonal EPC line (T17b-EPC) on vascularization and fibrovascular granulation tissue formation after suspension in a fibrine matrix followed by subcutaneous implantation in a separation chamber in rats. EPC were fluorescently labelled in vitro prior to implantation. After 3, 7 or 14 days, animals were killed followed by explantation and histological analysis of the constructs. Before the end of the experiment, Bandeirea Simplicifolia lectin was intravenously injected to mark the vascular ingrowth into the implanted constructs. The transplanted cells were histologically detected at all time-points and located almost exclusively within the fibrin matrix at day 3 but the number of cells in the clot continuously decreased over day 7 to day 14. Conversely, cells were detected within the newly formed granulation tissue in increasing numbers from day 3 over day 7 to day 14. Transplanted cells were also found in the intermuscular septa. Cell viability was confirmed by use of an EPC clone expressing β-galactosidase. Fluorescence microscopy demonstrated integration of the transplanted cells in newly formed blood vessels within the fibrovascular granulation tissue adjacent to the fibrin clot. Presence of cells in the fibrin clot lead to thicker granulation tissue and an increased blood vessel diameter compared to cell-free controls. Organ standard controls showed presence of the transplanted cells in spleens at day 14 after transplantation. In summary, EPC exhibited biological activity after subcutaneous implantation in a fibrin matrix by migration from the fibrin clot into the granulation tissue and along intermuscular septae, undergoing differentiation into mature endothelial cells and integration into newly formed blood vessels and altering fibrovascular granulation tissue development. EPC may hold promise to modulate blood vessel formation in bioartificial matrices.

Indexed as

CapillariesStem Cell TransplantationTissue EngineeringAnimalsBiocompatible MaterialsCell DifferentiationCell LineEndothelial CellsFibrinGranulation TissueMaleMiceNeovascularization, PhysiologicPlant LectinsRatsRats, Inbred LewBiocompatible MaterialsFibrinGriffonia simplicifolia lectinsPlant Lectins

Identifiers

PMID21199325
PMCPMC3822956
OpenAlexW2136492061

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.